The Prospective Antifungal Therapy Alliance® Registry: A Two-Centre Canadian Experience

Shariq Haider; Coleman Rotstein; David Horn; Michel Laverdiere; Nkechi Azie

doi:10.1155/2014/308169

Canadian Journal of Infectious Diseases and Medical Microbiology (Jan 2014)

The Prospective Antifungal Therapy Alliance® Registry: A Two-Centre Canadian Experience

Shariq Haider,
Coleman Rotstein,
David Horn,
Michel Laverdiere,
Nkechi Azie

Affiliations

Shariq Haider: Hamilton Health Sciences, McMaster University, Hamilton, Canada
Coleman Rotstein: University Health Network, University of Toronto, Toronto, Ontario, Canada
David Horn: David Horn, LLC, Doylestown, Pennsylvania, USA
Michel Laverdiere: University of Montreal, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada
Nkechi Azie: Astellas Pharma Global Development, Northbrook, Illinois, USA

DOI: https://doi.org/10.1155/2014/308169
Journal volume & issue: Vol. 25, no. 1
pp. 17 – 23

Abstract

Read online

BACKGROUND: The Prospective Antifungal Therapy Alliance® registry is a prospective surveillance study that collected data on the diagnosis, management and outcomes of invasive fungal infections (IFIs) from 25 centres in North America from 2004 to 2008.

Published in Canadian Journal of Infectious Diseases and Medical Microbiology

ISSN: 1712-9532 (Print); 1918-1493 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases; Science: Microbiology
Website: https://onlinelibrary.wiley.com/journal/9575

About the journal